Skip to content
MedsAcross

Medicine

Oxycodone 5 mg capsule

Oxycodone · Oral
Available on requestPrescription onlyUS FDAControlled, schedule CIIGeneric name

Oxycodone 5 mg capsule is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F), excursions permitted at 15° to 30°C (59°…

Key facts

Active ingredient (INN)
Oxycodone
Brand
Sold under the generic name
Strength
5 mg
Dosage form
Capsule
Route
Oral
Packs
100 capsules, 30 capsules, 500 capsules and 3 more
Manufacturers
Novel LaboratoriesIndiaKVK-TechANI Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F), excursions permitted at 15° to 30°C (59° to 86°F). Store Oxycodone Hydrochloride Capsules securely and dispose of properly.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Schedule CII
ATC code
N02AA05 Oxycodone
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
20 August 2015
Identifiers
RxCUI 1049696DailyMed set ID 5df92fed-6194-4905-9ef2-9eed0d2e8086, 69410bf3-0d3a-41f9-b10a-c4ee3770f728, 338b5391-e5f7-40a2-8b15-57f47cbc4813NDC 62559-167, 40032-950, 10702-023Application ANDA205177, ANDA204752, ANDA202773

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 capsule in 1 bottle40032-950-01Novel LaboratoriesIndia24 August 2015
30 capsule in 1 bottle40032-950-03Novel LaboratoriesIndia24 August 2015
500 capsule in 1 bottle40032-950-50Novel LaboratoriesIndia24 August 2015
100 capsule in 1 bottle62559-167-01ANI Pharmaceuticals10 June 2016
100 capsule in 1 bottle10702-023-01Kvk-Tech20 August 2015
60 capsule in 1 bottle10702-023-06Kvk-Tech20 August 2015

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 26 October 1998Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Oxycodone

Clinical summary

Oxycodone is an opioid agonist indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. It is available as tablets, oral solution and extended-release tablets. MedsAcross supplies Oxycodone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Oxycodone

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Oxycodone 5 mg capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.